Short summary

The aim of this study was to compare the short-time clinical and oncological outcomes for colonic and rectal cancer surgery in respectively robotic assisted and laparoscopic surgery.

Rationale

Laparoscopic colorectal surgery (LCS) has existed for more than 20 year. The benefits of LCS and its superiority to open colorectal surgery (OCS) in terms of less pain, fewer wound complication and improved cosmetic outcome are already described. The disadvantages of LCS are a long learning curve, suboptimal ergonomics, bad camera precision because of tremor and a 2D-view. In case of oncological results LCS has shown same 3-5 year survival and recurrence rates compared to OCS. In the past 15-20 years, robotic colorectal surgery (RCS) has gained impact. This new surgical method has not shown its superiority in term of short time or pathological outcomes in meta-analysis compared to LCS. It is associated with longer operating times and higher total costs, but has several benefits; eg. a reduced risk of conversion compared with LCS. Additionally, RCS has eliminated tremor, camera is in 3D-view and the instruments has a 7 of freedom, making rectal surgery in narrow pelvis more easy than LCS. 

Description of the cohort

This was a retrospective case-control study of patients undergoing robotic and laparoscopic surgery for colonic and rectal cancer in the period of may 2017 until date at surgical department, Sygehus Sønderjylland

Data and biological material

Retrospective review of patient material

Collaborating researchers and departments

Department of Surgery, Hospital of Southern Jutland

• Physician Randi M. Simonsen
• Consultant Mirjana Komljen
• Consultant MBM, Per Helligsø
• Consultant Mark Bremholm Ellebæk, PhD